Wealthspire Advisors, LLC Illumina, Inc. Transaction History

Wealthspire Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$303.87 - $423.8 $194,172 - $270,808	-639 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $221,911 - $269,549	639 New	639 $243,000
Q2 2021 Aug 13, 2021	SELL	$372.84 - $481.5 $1.85 Million - $2.39 Million	-4,964 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $212,071 - $296,294	587 Added 13.41%	4,964 $1.91 Million
Q4 2020 Feb 16, 2021	BUY	$292.7 - $370.96 $210,158 - $266,349	718 Added 19.62%	4,377 $1.62 Million
Q3 2020 Nov 16, 2020	BUY	$268.51 - $400.74 $751,290 - $1.12 Million	2,798 Added 324.97%	3,659 $1.13 Million
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $335,449 - $487,897	-1,308 Reduced 60.3%	861 $319,000
Q1 2020 May 12, 2020	BUY	$209.2 - $335.53 $310,452 - $497,926	1,484 Added 216.64%	2,169 $592,000
Q4 2019 Feb 14, 2020	BUY	$288.29 - $335.49 $197,478 - $229,810	685 New	685 $227,000
Q1 2019 May 08, 2019	SELL	$272.57 - $321.18 $31,072 - $36,614	-114 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$272.46 - $366.54 $31,060 - $41,785	114 New	114 $34,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $20.6B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthspire Advisors, LLC with notifications on news.